← Back to all trials
Recruiting
NCT05653011
Predictors of Prognosis in IBD Patients
Conditions: Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
Sex: All
Ages: 18 Years – N/A
Enrollment: 100
Sponsor: Seoul National University Bundang Hospital
Location: Korea, Republic of
Summary
A study of clinical characteristics and potential prognostic factors in inflammatory bowel disease
Eligibility Criteria
Inclusion Criteria:control group: Patients who do not have colitis, cancer, and advanced polyp (the number of polyps ≥ 3, the size of polyps ≥ 1cm, high-grade adenoma, villous adenoma)TNF-α inhibitor-naive IBD group: IBD patients who do not have a history of TNF-α inhibitor treatmentTNF-α inhibitor-treated IBD group: IBD patients who are treated with TNF-α inhibitorExclusion Criteria:Age under 18 yearsPatients who were treated with antibiotics or probiotics within the last 3 months
Source: ClinicalTrials.gov (NCT05653011). StuddyBuddy aggregates publicly available trial information.
